Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy. Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, et al. Cancer Res 2023;83:4095-4111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, et al. Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy. Cancer Res 2023;83:4095-4111.
PMID: 37729426